TAK-242 improves sepsis-associated acute kidney injury in rats by inhibiting the TLR4/NF-κB signaling pathway

Yan-mei Xia,Yu-qian Guan,Ji-fang Liang,Wei-dong Wu
DOI: https://doi.org/10.1080/0886022x.2024.2313176
IF: 3.222
2024-02-16
Renal Failure
Abstract:Objective This study was designed to observe the effect of toll-like receptor 4 (TLR4)/nuclear factor kappa-B (NF-κB) pathway activity on sepsis-associated acute kidney injury (SA-AKI), thereby providing new considerations for the prevention and treatment of SA-AKI.
urology & nephrology
What problem does this paper attempt to address?
The problem this paper attempts to address is whether TAK-242 can improve sepsis-induced acute kidney injury (SA-AKI) by inhibiting the TLR4/NF-κB signaling pathway. Specifically, the researchers constructed a model of sepsis-induced acute kidney injury to observe the effects of TAK-242 on this injury. They hope that this study will provide new ideas and methods for the prevention and treatment of SA-AKI. The main objectives of the study include: 1. **Evaluate the preventive effect of TAK-242 on SA-AKI**: By detecting kidney injury markers in serum (such as urea nitrogen, creatinine, cystatin C, etc.) and pathological changes in kidney tissue, to assess the protective effect of TAK-242. 2. **Explore the mechanism of action of TAK-242**: By detecting levels of oxidative stress, mitochondrial function, levels of inflammatory factors, and the expression of proteins related to the TLR4/NF-κB signaling pathway, to reveal how TAK-242 alleviates kidney injury by inhibiting the TLR4/NF-κB signaling pathway. The results of the study indicate that TAK-242 can significantly reduce the levels of kidney injury markers in serum, alleviate pathological damage to kidney tissue, reduce oxidative stress levels, improve mitochondrial function, and decrease inflammatory responses. These findings provide strong support for the potential of TAK-242 in the prevention and treatment of SA-AKI.